Clinical worsening: need for invasive mechanical ventilation, or death at up to day 28 · people with moderate to severe disease (WHO scale 4–9); all studies contributing results to the summary of findings table included people…
Azithromycin showed no clear difference in worsening of clinical status: participants with clinical… compared with placebo or standard of care alone (moderate certainty).
1 finding from 1 review
Clinical improvement: discharged alive ( · people with moderate to severe disease (WHO scale 4–9); all studies contributing results to the summary of findings table included people…
Azithromycin showed no clear difference in improvement of clinical status: participants discharged alive at day… compared with placebo or standard of care alone (moderate certainty).
1 finding from 1 review
All‐cause mortality at day 28 · all trials contributing results to the summary of findings table included people with mild disease (WHO scale 1 to 3)§
Azithromycin showed no clear difference in all‐cause mortality at day 28 compared with placebo or standard of care alone (low certainty).
1 finding from 1 review
Admission to hospital or death within 28 days · all trials contributing results to the summary of findings table included people with mild disease (WHO scale 1 to 3)§
Azithromycin showed no clear difference in admission to hospital or death within 28 days compared with placebo or standard of care alone (low certainty).
1 finding from 1 review
All‐cause mortality assessed up to day 28 · individuals with moderate or severe COVID‐19
1 finding from 1 review
Adverse events within 28 days · people with SARS‐CoV‐2 infection and asymptomatic or mild disease
1 finding from 1 review
Serious adverse events within 28 days · people with SARS‐CoV‐2 infection and asymptomatic or mild disease
1 finding from 1 review
Clinical worsening: need for invasive mechanical ventilation, or death at up to day 28 · individuals with moderate or severe COVID‐19
1 finding from 1 review
Improvement of clinical status: participants discharged alive up to day 28 without clinical deterioration or death · individuals with moderate or severe COVID‐19
1 finding from 1 review
All‐cause mortality up to day 28 · people with SARS‐CoV‐2 infection and asymptomatic or mild disease
1 finding from 1 review
Admission to hospital or death within 28 days · people with SARS‐CoV‐2 infection and asymptomatic or mild disease
1 finding from 1 review
Length of hospital stay · adults with acute stroke
Stroke ward showed no clear difference in length of stay (days) in a hospital or institution (Analysis 2.5) compared with general medical ward (low certainty).
1 finding from 1 review
Length of hospital stay · adults with acute stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Length of hospital stay · adults with acute stroke
It is very uncertain whether mixed rehabilitation ward changes length of stay (days) in a hospital or institution (Analysis 4.5) compared with general medical ward (very low certainty).
1 finding from 1 review
Length of hospital stay · adults with acute stroke
Organised inpatient (stroke unit) care showed no clear difference in length of stay (days) in a hospital or institution (Analysis 1.5) compared with alternative service (low certainty).
1 finding from 1 review
Rate of weight gain (g/kg/day) · preterm infants
1 finding from 1 review
Duration of hospital admission (days) · preterm infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Rate of weight gain (g/kg/day) · preterm infants
1 finding from 1 review
Length of hospital stay · preterm infants
1 finding from 1 review
Death or any stroke between randomisation and 30 days after treatment · people with symptomatic carotid stenosis
Carotid artery stenting leads to higher death or any stroke between randomisation and 30 days after treatment compared with endarterectomy (high certainty).
1 finding from 1 review